General Information of Drug Therapeutic Target (DTT) (ID: TTCPG9S)

DTT Name 5-HT 1E receptor (HTR1E)
Synonyms Serotonin receptor 1E; S31; 5-hydroxytryptamine receptor 1E; 5-HT1E; 5-HT-1E; 5-HT 1E
Gene Name HTR1E
DTT Type
Successful target
[1]
BioChemical Class
GPCR rhodopsin
UniProt ID
5HT1E_HUMAN
TTD ID
T84117
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MNITNCTTEASMAIRPKTITEKMLICMTLVVITTLTTLLNLAVIMAIGTTKKLHQPANYL
ICSLAVTDLLVAVLVMPLSIIYIVMDRWKLGYFLCEVWLSVDMTCCTCSILHLCVIALDR
YWAITNAIEYARKRTAKRAALMILTVWTISIFISMPPLFWRSHRRLSPPPSQCTIQHDHV
IYTIYSTLGAFYIPLTLILILYYRIYHAAKSLYQKRGSSRHLSNRSTDSQNSFASCKLTQ
TFCVSDFSTSDPTTEFEKFHASIRIPPFDNDLDHPGERQQISSTRERKAARILGLILGAF
ILSWLPFFIKELIVGLSIYTVSSEVADFLTWLGYVNSLINPLLYTSFNEDFKLAFKKLIR
CREHT
Function
Functions as a receptor for various alkaloids and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. G-protein coupled receptor for 5-hydroxytryptamine (serotonin).
KEGG Pathway
cAMP signaling pathway (hsa04024 )
Neuroactive ligand-receptor interaction (hsa04080 )
Serotonergic synapse (hsa04726 )
Reactome Pathway
G alpha (i) signalling events (R-HSA-418594 )
Serotonin receptors (R-HSA-390666 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Metergolin DMJFP6G Hyperprolactinaemia 5A60.1 Approved [1]
------------------------------------------------------------------------------------
15 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
1-naphthylpiperazine DM6BIWK Discovery agent N.A. Investigative [1]
2-(5-fluoro-1H-indol-3-yl)ethanamine DMHW5FT Discovery agent N.A. Investigative [1]
2-methyl-5-HT DM1S5CB N. A. N. A. Investigative [2]
5-BODMT DM7BWG5 Discovery agent N.A. Investigative [3]
5-CT DM260KD Discovery agent N.A. Investigative [1]
9-OH-risperidone DMGORXQ Discovery agent N.A. Investigative [4]
alpha-methyl-5-HT DMCAYXF Discovery agent N.A. Investigative [1]
B173 DMN2XTQ Discovery agent N.A. Investigative [5]
BRL-15572 DMM61Y2 Discovery agent N.A. Investigative [6]
BRL54443 DM3TWBU Discovery agent N.A. Investigative [7]
EDMT DMS3AXK Discovery agent N.A. Investigative [8]
lysergol DM1OHF8 Discovery agent N.A. Investigative [9]
m-chlorophenylpiperazine DMM1J2D Discovery agent N.A. Investigative [1]
TFMPP DMAC8TP Discovery agent N.A. Investigative [1]
[3H]5-HT DMYJXV7 Discovery agent N.A. Investigative [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Investigative Drug(s)

References

1 Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor. Eur J Pharmacol. 2004 Jan 26;484(2-3):127-39.
2 Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):408-12.
3 Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. J Pharmacol Exp Ther. 2011 Jun;337(3):860-7.
4 Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73.
5 The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res. 2007 Jan;31(1):11-8.
6 SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):312-20.
7 Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. J Pharmacol Exp Ther. 2001 Apr;297(1):88-95.
8 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. J Med Chem. 2000 Mar 9;43(5):1011-8.
9 Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors. J Neurochem. 1996 Nov;67(5):2096-103.
10 Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5517-21.